James Greenbaum

Sr. Director, CMC Quality Strategy And Operations at Recursion Pharmaceuticals

James Greenbaum has extensive experience in quality strategy and operations, currently serving as the Sr. Director of CMC Quality Strategy and Operations at Recursion since December 2021. Prior to this role, James held the position of Director of Site Quality at Fresenius Medical Care North America from May 2017 to December 2021, overseeing a variety of quality functions. Previous experience includes serving as Associate Director of Compliance and Quality Engineering at Actavis and various roles at Watson Pharmaceuticals, culminating in managerial positions in quality engineering. James began a career at Wyeth in 1995, where roles included Validation Compliance Coordinator and Supervisor of the Influenza Refining Unit. Educational qualifications include a Master’s degree in QA/RA from Temple School of Pharmacy and a Bachelor of Science in Biology from Elizabethtown College.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Recursion Pharmaceuticals

13 followers

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.